Last Price
0.024
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Overview
Market Cap
75 Million
Shares Outstanding
3 Billion
Avg Volume
5,148,445
Avg Price (50 Days)
0.03
Avg Price (200 Days)
0.04
PE Ratio
-2.40
EPS
-0.01
Earnings Announcement
24-Feb-2025
Previous Close
0.03
Open
0.02
Day's Range
0.024 - 0.025
Year Range
0.02 - 0.099
Trading Volume
2,677,763
Price Change Highlight
1 Day Change
-4.00%
5 Day Change
-4.00%
1 Month Change
-4.00%
3 Month Change
-4.00%
6 Month Change
-41.46%
Ytd Change
15.87%
1 Year Change
15.87%
3 Year Change
-83.11%
5 Year Change
-23.97%
10 Year Change
-35.38%
Max Change
-96.35%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
Top Articles
1
CEO Morning Brief
#
Stock
Score
Daily Stocks
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
